Performance Indicators Performance Indicators Performance indicators concerning Environment Health and Safety (EHS) are summarized here.
History of the logo History of the logo Overview of the history of the corporate logo of Boehringer Ingelheim, from the founding years of the company until today
From social worker to joining the pharmaceutical industry From social worker to joining the pharmaceutical industry Patient centricity: How Miyuki Ono contributes to our diverse workforce with her experience as a social worker and helps patients in Japan
LastMile increases access to veterinary care in Africa LastMile increases access to veterinary care in Africa Boehringer Ingelheim’s LastMile initiative reaches over 40,000 smallholder farmers in Sub-Saharan Africa increasing access to veterinary medicine
We are Global Top Employer 2024 We are Global Top Employer 2024 Global Top Employer certification reflects our impactful people development with high scores in development and steering practices as well as benefits on employee wellbeing.
Health for all: How can we contribute to inclusive access? Health for all: How can we contribute to inclusive access? What drives us to improve the health of humans and animals worldwide
Why is Diversity, Equity and Inclusion important to us? Why is Diversity, Equity and Inclusion important to us? Why is Diversity, Equity and Inclusion important to us?
Tips to help you start your patient advocacy journey Tips to help you start your patient advocacy journey Advocating for yourself as a patient can be daunting. Jeff Dunn, President of Union for International Cancer Control (UICC), shares some tips
T-cell engagers: Reawakening T-cells to fight cancer T-cell engagers: Reawakening T-cells to fight cancer Learn how we are taking cancer on through our approach to immuno-oncology and our T-cell engagers plarform
Improving Access to Stroke Care Improving Access to Stroke Care Angels Initiative named Best Practice example by the Access to Medicine Index
Option to Acquire Trutino Biosciences Option to Acquire Trutino Biosciences Option to Acquire Trutino Biosciences
Joint venture to fight Antimicrobial Resistance Joint venture to fight Antimicrobial Resistance Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
“Rapid progress towards clinical candidates” “Rapid progress towards clinical candidates” Boehringer Ingelheim forms a joint venture to create the next generation of antimicrobials.
Ukraine Help: In a nine-seater to Poland Ukraine Help: In a nine-seater to Poland Boehringer Ingelheim employee Eugen Pushchyk rescues refugees from Ukraine
Advice to Fellow Patients Advice to Fellow Patients People living with cancer share their advice for fellow patients, from checking information sources to living in the present moment.
Say no to the uninvited guests Say no to the uninvited guests Find out how to keep fleas, ticks and worms away from your cat.
Targeting HER2 in cancer: The story of zongertinib Targeting HER2 in cancer: The story of zongertinib We discovered zongertinib, an HER2 tyrosine kinase inhibitor, being developed as a potential oral treatment for people with HER2-mutated NSCLC